Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Becton, Dickinson and Company

NYSE

Market Cap.

68.29B

Avg. Volume

1.33M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Becton, Dickinson and Company!

Still processing it, give me a bit more time...

Becton, Dickinson and Company News

Becton, Dickinson and Company Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Instruments & Supplies
bd.com

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Becton, Dickinson and Company Earnings & Revenue

Becton, Dickinson and Company Financials

Table Compare

Compare BDX metrics with:

   

Earnings & Growth

BDX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

BDX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

BDX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

BDX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Becton, Dickinson and Company Income

Becton, Dickinson and Company Balance Sheet

Becton, Dickinson and Company Cash Flow

Becton, Dickinson and Company Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Becton, Dickinson and Company Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

3.76

Payment DateDividendFrequency
2024-06-280.95Quarterly
2024-03-290.95Quarterly
2023-12-290.95Quarterly
2023-09-290.91Quarterly
2023-06-300.91Quarterly

Historical Market Cap

Shares Outstanding

Becton, Dickinson and Company Executives

NameRole
Mr. Thomas E. Polen Jr.President, Chief Executive Officer & Chairman
Ms. Shana Carol NealExecutive Vice President & Chief People Officer
Mr. Michael GarrisonExecutive Vice President & President of Medical segment
Mr. Christopher J. DelOreficeExecutive Vice President & Chief Financial Officer
Mr. David B. HickeyExecutive Vice President & President of Life Sciences Segment
NameRoleGenderDate of BirthPay
Mr. Thomas E. Polen Jr.President, Chief Executive Officer & ChairmanMale19733.46M
Ms. Shana Carol NealExecutive Vice President & Chief People OfficerFemale19661.79M
Mr. Michael GarrisonExecutive Vice President & President of Medical segmentMale19701.73M
Mr. Christopher J. DelOreficeExecutive Vice President & Chief Financial OfficerMale19721.6M
Mr. David B. HickeyExecutive Vice President & President of Life Sciences SegmentMale19641.11M

Becton, Dickinson and Company Insider Trades

Date15 May
NameGoette Roland
RoleEVP and President EMEA
TransactionDisposed
TypeS-Sale
Shares800
Date15 May
NameGoette Roland
RoleEVP and President EMEA
TransactionDisposed
TypeS-Sale
Shares1400
Date15 May
NameGoette Roland
RoleEVP and President EMEA
TransactionDisposed
TypeS-Sale
Shares1100
Date13 May
NameGoette Roland
RoleEVP and President EMEA
TransactionDisposed
TypeS-Sale
Shares1700
Date13 May
NameGoette Roland
RoleEVP and President EMEA
TransactionDisposed
TypeS-Sale
Shares1572
DateNameRoleTransactionTypeShares
15 MayGoette RolandEVP and President EMEADisposedS-Sale800
15 MayGoette RolandEVP and President EMEADisposedS-Sale1400
15 MayGoette RolandEVP and President EMEADisposedS-Sale1100
13 MayGoette RolandEVP and President EMEADisposedS-Sale1700
13 MayGoette RolandEVP and President EMEADisposedS-Sale1572

Discover More

Streamlined Academy

Becton, Dickinson and Company

NYSE

Market Cap.

68.29B

Avg. Volume

1.33M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Becton, Dickinson and Company News

Becton, Dickinson and Company Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Becton, Dickinson and Company Earnings & Revenue

Becton, Dickinson and Company Income

Becton, Dickinson and Company Balance Sheet

Becton, Dickinson and Company Cash Flow

Becton, Dickinson and Company Financials Over Time

Becton, Dickinson and Company Executives

NameRole
Mr. Thomas E. Polen Jr.President, Chief Executive Officer & Chairman
Ms. Shana Carol NealExecutive Vice President & Chief People Officer
Mr. Michael GarrisonExecutive Vice President & President of Medical segment
Mr. Christopher J. DelOreficeExecutive Vice President & Chief Financial Officer
Mr. David B. HickeyExecutive Vice President & President of Life Sciences Segment
NameRoleGenderDate of BirthPay
Mr. Thomas E. Polen Jr.President, Chief Executive Officer & ChairmanMale19733.46M
Ms. Shana Carol NealExecutive Vice President & Chief People OfficerFemale19661.79M
Mr. Michael GarrisonExecutive Vice President & President of Medical segmentMale19701.73M
Mr. Christopher J. DelOreficeExecutive Vice President & Chief Financial OfficerMale19721.6M
Mr. David B. HickeyExecutive Vice President & President of Life Sciences SegmentMale19641.11M

Becton, Dickinson and Company Insider Trades

Date15 May
NameGoette Roland
RoleEVP and President EMEA
TransactionDisposed
TypeS-Sale
Shares800
Date15 May
NameGoette Roland
RoleEVP and President EMEA
TransactionDisposed
TypeS-Sale
Shares1400
Date15 May
NameGoette Roland
RoleEVP and President EMEA
TransactionDisposed
TypeS-Sale
Shares1100
Date13 May
NameGoette Roland
RoleEVP and President EMEA
TransactionDisposed
TypeS-Sale
Shares1700
Date13 May
NameGoette Roland
RoleEVP and President EMEA
TransactionDisposed
TypeS-Sale
Shares1572
DateNameRoleTransactionTypeShares
15 MayGoette RolandEVP and President EMEADisposedS-Sale800
15 MayGoette RolandEVP and President EMEADisposedS-Sale1400
15 MayGoette RolandEVP and President EMEADisposedS-Sale1100
13 MayGoette RolandEVP and President EMEADisposedS-Sale1700
13 MayGoette RolandEVP and President EMEADisposedS-Sale1572

Streamlined Academy

Website screenshot
HealthcareMedical - Instruments & Supplies
bd.com

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Becton, Dickinson and Company!

Still processing it, give me a bit more time...

Becton, Dickinson and Company Financials

Table Compare

Compare BDX metrics with:

   

Earnings & Growth

BDX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

BDX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

BDX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

BDX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Becton, Dickinson and Company Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

3.76

Payment DateDividendFrequency
2024-06-280.95Quarterly
2024-03-290.95Quarterly
2023-12-290.95Quarterly
2023-09-290.91Quarterly
2023-06-300.91Quarterly

Becton, Dickinson and Company Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityBuy
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More